Current Ratio of Cytek Biosciences, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cytek Biosciences, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Cytek Biosciences, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 545%, a 20% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 545% -140% -20% 30 Sep 2025
Q2 2025 571% -141% -20% 30 Jun 2025
Q1 2025 619% -107% -15% 31 Mar 2025
Q4 2024 654% -86% -12% 31 Dec 2024
Q3 2024 685% -108% -14% 30 Sep 2024
Q2 2024 712% -159% -18% 30 Jun 2024
Q1 2024 726% -206% -22% 31 Mar 2024
Q4 2023 740% -273% -27% 31 Dec 2023
Q3 2023 793% -307% -28% 30 Sep 2023
Q2 2023 871% -311% -26% 30 Jun 2023
Q1 2023 933% -206% -18% 31 Mar 2023
Q4 2022 1013% 31 Dec 2022
Q3 2022 1100% 30 Sep 2022
Q2 2022 1182% 30 Jun 2022
Q1 2022 1139% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.